Brief: Aptose Biosciences Files Prospectus Relates To Offering Of Up To 21.5 Mln Common Shares Together With Warrants -SEC Filing
31/10/2024 10:52
Oct 31 (Reuters) -
* APTOSE BIOSCIENCES FILES PROSPECTUS RELATES TO OFFERING OF
UP TO
21.5 MILLION COMMON SHARES TOGETHER WITH WARRANTS -SEC FILING
Source text: ID:n0001193125-24-247920
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting